About Nuvonis

Nuvonis is a biotech company based in Vienna, Austria, providing innovative cell banks and technical support for vaccine development. The Nuvonis team is highly experienced in all aspects of vaccine production, both in small biotech companies up to major international pharmaceutical companies. We have identified several weak points in vaccine production that usually result in significant delays in product development, both on the side of cell substrates and in process development for production. Based on our experience, Nuvonis offers solutions that reduce development timelines, ensure optimal quality and prevent risks in your product development.

The fully characterised Nuvonis Vero cells (GMP) are cultivated without animal-derived media or protease additives and are non-tumorigenic beyond the end of production passage. This cell bank can be licensed for viral vaccine and vector manufacturing to immediately move into GMP production of your product.

To help you fulfil the most demanding timelines in your GMP production, the Nuvonis GMP Vero cells are now also available from a USA storage facility. There are no complicated transatlantic shipments and you can get GMP-grade and ready-to-use Vero cell banks for your production needs within days. With respect to GMP storage, we work with the renowned Charles River Laboratories and use their GMP-compliant facilities located in Wayne, PA and/or Shrewsbury, MA.

A proprietary fully characterised avian cell bank grows on microcarrier or in suspension and can be licensed for viral vaccine and vector manufacturing.

We are offering proprietary and efficient virus purification processes for the generation of high-purity vaccine bulk drug substance with low host cell DNA and protein impurities.